Mix & match. Save up to 25%. Shop now

Prime Peptides Wolverine Blend 20mg research vial

Wolverine Blend 20mg

฿3,190

Batch BPTB20-2609A

Bundle and save
Bundle & save up to 25%Mix & match. Every vial in your cart counts.

฿3,000 away from free shippingTracked post

Pay with

PromptPayKBankSCBBangkok BankKrungsriUSDTUSDCCash

10% off with crypto. How it works

Arrives tomorrow in BangkokBy Grab, every day. Paid and confirmed by 3 PM Bangkok time.
Rest of Thailand: Wed 4 – Thu 5 NovTracked post. Free shipping on orders from ฿3,000

The lab report for the vial you’ll get.

Every batch is tested by an independent lab before it goes on sale. Match the batch number on your vial to its report.

Wolverine Blend 20 mg

98.97%Purity, HPLC
Batch
BPTB20-2609A
Net content
22.33 mg total
Identity (HPLC)
Confirmed
Endotoxins
Pass
Lab
Vanguard Laboratory
Reported
16 Oct 2026
Report number
V261007-11 004
Verify at Vanguard

Tested by Vanguard LaboratoryDownload PDF

See all tests

Every Wolverine Blend test · 1 test

What’s in the vial.

Wolverine is a co-lyophilized research blend of BPC-157 and TB-500, two peptides studied together in tissue-repair research.

For laboratory research use only
In this vial
20 mg total co-lyophilized powder
Blend of
BPC-157 10 mg + thymosin beta-4 10 mg
Store sealed
−20°C · protect from light
Once mixed
2-8°C · follow your lab protocol for how long

Two components. Two separate research records.

Published studies describe BPC-157 and thymosin beta-4 independently. This page keeps those research contexts separate and does not claim that co-lyophilization creates a proven combined effect.

  • BPC-157

    A synthetic 15-amino-acid peptide studied mainly in cell and animal models involving gastrointestinal, vascular and connective-tissue endpoints.

  • Thymosin beta-4

    A 43-amino-acid actin-binding peptide studied in cell migration, cytoskeletal organization and tissue-repair models.

  • Distinct pathways

    The components have different molecular identities and research histories; one should not be used as a proxy for the other.

  • Fixed-formulation caveat

    The literature below concerns the individual components. It does not establish synergy, equivalence or efficacy for this commercial blend.

Common questions

Research context, batch testing, storage and verification for Wolverine Blend 20mg.

What is Wolverine Blend 20mg?

Wolverine Blend 20mg is a co-lyophilized research formulation containing 10mg of BPC-157 and 10mg of thymosin beta-4 per vial. It is supplied strictly for in-vitro and laboratory research.

How much of each peptide is in the vial?

The labeled total is 20mg: 10mg BPC-157 and 10mg thymosin beta-4. The measured total for the current batch is in its lab report on this page.

Has this exact blend been studied as a fixed formulation?

The selected literature on this page concerns BPC-157 and thymosin beta-4 separately. It should not be interpreted as direct evidence of synergy or a proven combined effect for this fixed formulation.

What is BPC-157 studied for?

BPC-157 has primarily been investigated in preclinical cell and animal models, including tendon-cell migration, angiogenesis-related signaling and gastrointestinal injury models. Controlled human evidence remains limited.

What is thymosin beta-4 studied for?

Thymosin beta-4 is an actin-binding peptide investigated in cell migration, cytoskeletal organization, angiogenesis and tissue-repair models. Findings from those models do not establish a clinical use.

Scroll to Top